BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33217522)

  • 1. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
    Lee F; Mielniczuk LM
    Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
    Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y
    J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension due to left heart disease.
    Vachiéry JL; Tedford RJ; Rosenkranz S; Palazzini M; Lang I; Guazzi M; Coghlan G; Chazova I; De Marco T
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
    Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension associated with left-sided heart disease.
    Maeder MT; Schoch OD; Kleiner R; Joerg L; Weilenmann D; Swiss Society For Pulmonary Hypertension
    Swiss Med Wkly; 2017; 147():w14395. PubMed ID: 28102878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic Pressure Difference to Classify Pulmonary Hypertension in the Assessment of Heart Transplant Candidates.
    Wright SP; Moayedi Y; Foroutan F; Agarwal S; Paradero G; Alba AC; Baumwol J; Mak S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension due to left heart diseases.
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under pressure: pulmonary hypertension associated with left heart disease.
    Farber HW; Gibbs S
    Eur Respir Rev; 2015 Dec; 24(138):665-73. PubMed ID: 26621980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension associated with left heart disease.
    Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
    Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update in approaches to pulmonary hypertension because of left heart disease.
    Kennedy JLW; Mihalek AD
    Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension – a common condition in left heart disease].
    Lundgren J; Rådegran G
    Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension associated with left heart disease (group 2)].
    Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
    Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
    Naeije R; D'Alto M
    Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction.
    Inampudi C; Silverman D; Simon MA; Leary PJ; Sharma K; Houston BA; Vachiéry JL; Haddad F; Tedford RJ
    Chest; 2021 Dec; 160(6):2232-2246. PubMed ID: 34391755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.
    Rao SD; Menachem JN; Birati EY; Mazurek JA
    Curr Heart Fail Rep; 2019 Oct; 16(5):119-129. PubMed ID: 31292856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Post- and Precapillary Pulmonary Hypertension in Patients With Heart Failure.
    Rezaee ME; Nichols EL; Sidhu M; Brown JR
    Clin Cardiol; 2016 Nov; 39(11):658-664. PubMed ID: 27768231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
    Held M; Weiner S; Walthelm J; Joa F; Hoffmann J; Güder G; Pfeuffer-Jovic E
    Pneumologie; 2022 Oct; 76(10):689-696. PubMed ID: 36257308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.